STING-Activating Nanomedicines in Cancer Immunotherapy: Mechanisms, Design, and Therapeutic Outcomes
Fields of Study & Subjects
interferon and immune responses
Nanoplatforms for cancer theranostics
Cytokine Signaling Pathways and Interactions
Publication details
- Journal / source
- International Immunopharmacology
- Publisher
- Elsevier BV
- Volume
- 180
- Pages
- 116692–116692
- Publication date
- 26 April 2026
- Language
- EN